Advanced Search
Search Results
6557 total results found
86 - Stopping
Stopping 90 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 Olanzapine long-acting injection Olanzapine pamoate (embonate, in some countries) is a very poorly water-soluble salt ester of olanzapine. An aqueous suspension of olanzapine pamoate, w...
87 - Post injection delirium sedation syndrome
Post-injection delirium sedation syndrome Schizophrenia and related psychoses CHAPTER 1 Post-injection delirium sedation syndrome Although the precise mechanism of post-injection delirium sedation syndrome (PDSS) remains unclear, it is thought to occur when ...
88 - References
References 92 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References Heres S, et al. Pharmacokinetics of olanzapine long-acting injection: the clinical perspective. Int Clin Psychopharmacol 2014; 29:299–312. Mitchell M, et al. Single- and m...
89 - Paliperidone palmitate long acting injection
Paliperidone palmitate long-acting injection
90 - Paliperidone long acting injection 1 monthly
Paliperidone long-acting injection 1-monthly Schizophrenia and related psychoses CHAPTER 1 Paliperidone palmitate long-acting injection Paliperidone (9-hydroxyrisperidone) is the major active metabolite of risperidone. Paliperidone palmitate is the ester pro...
91 - Paliperidone long acting injection 3 monthly
Paliperidone long-acting injection 3-monthly Schizophrenia and related psychoses CHAPTER 1 Paliperidone long-acting injection 3-monthly Paliperidone LAI 3-monthly (PP3M) is indicated for patients who are clinically stable on PP1M and do not require dose adj...
92 - Paliperidone LAI 6 monthly (PP6M)
Paliperidone LAI 6-monthly (PP6M) 96 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 (Table 1.20). Dose adjustments should not be necessary but may be made at 3-monthly intervals thereafter; however, the full response to the new dose may not be a...
93 - References
References Schizophrenia and related psychoses CHAPTER 1 Dose adjustments should not be needed but can be made every 6 months based on patient response and tolerability. Any dose change may not be apparent in respect to clinical effects for several months owin...
94 - Risperidone long acting injection
Risperidone long-acting injection
95 - Risperidone intramuscular long acting injecti
Risperidone intramuscular long-acting injections Schizophrenia and related psychoses CHAPTER 1 Risperidone long-acting injection In this section we give brief details on the range of risperidone LAIs (RLAIs) available around the world in 2024. We have done ou...
96 - Risperidone subcutaneous long acting injectio
Risperidone subcutaneous long-acting injections Schizophrenia and related psychoses CHAPTER 1 Risperidone ISM® (Risvan, Okedi) Risperidone ISM is an injectable suspension of risperidone suitable for stable patients who have previously responded and tolerated r...
97 - References
References 104 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References Knox ED, et al. Clinical review of a long-acting, injectable formulation of risperidone. Clin Ther 2004; 26:1994–2002. Wilson WH. A visual guide to expected blood levels o...
98 - Penfluridol weekly
Penfluridol weekly
99 - Background
Background
01 - Lithium
Lithium
02 - Mechanism of action
Mechanism of action
03 - Clinical indications
Clinical indications The Maudsley® Prescribing Guidelines in Psychiatry, Fifteenth Edition. David M. Taylor, Thomas R. E. Barnes and Allan H. Young. © 2025 David M. Taylor. Published 2025 by John Wiley & Sons Ltd. Chapter 2 Lithium Mechanism of action Lithium ...
04 - Lithium and suicide
Lithium and suicide